Efficacy and safety of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in hemodialysis patients with diabetic nephropathy: A randomized open-label prospective trial

Autor: Abe, Masanori, Higuchi, Terumi, Moriuchi, Masari, Okamura, Masahiro, Tei, Ritsukou, Nagura, Chinami, Takashima, Hiroyuki, Kikuchi, Fumito, Tomita, Hyoe, Okada, Kazuyoshi
Zdroj: In Diabetes Research and Clinical Practice June 2016 116:244-252
Databáze: ScienceDirect